Chronic Respiratory Diseases: A Silent Health Crisis
Across South Africa and the globe, a silent scourge is devastating public health. Chronic respiratory diseases (CRDs), including asthma and chronic obstructive pulmonary disease (COPD), remain significantly underreported. Despite their prevalence, they receive far less attention than infectious diseases…. Membership Required You must be a member to access this content.View Membership LevelsAlready a member? Log...
Aspen Pharmacare Debt-Free: Strategic Shift To GLP-1 Injectables
Aspen Pharmacare Debt-Free marks a pivotal moment in its history as it shifts focus toward GLP-1 injectables like semaglutide.
Discovery’s Interim Results Highlight Strong Growth
Learn how Discovery’s interim results reflect a 22% increase in normalised profit, demonstrating resilience in a fluctuating market.
Local Pharmaceutical Manufacturing and Health Security
Join the discussion on local pharmaceutical manufacturing versus cost in South Africa's contentious R15.5bn AIDS drug tender situation.
Pandemic Preparedness and Prevention: South Africa’s New Shield
Discover how Pandemic Preparedness and Prevention efforts in South Africa aim to improve bio-surveillance and health security.
Mediclinic Restructuring Deal: Remgro and MSC to Split Assets
Remgro and MSC announce a Mediclinic restructuring deal that splits Southern African and Swiss assets to streamline healthcare operations.
HIV Treatment Retention: South Africa’s Plan for 1.1m Patients
SA faces a crisis in HIV treatment retention as 1.1 million patients disengage from care. The "Close the Gap" campaign aims to fix this.
Aspen Targets Mounjaro Expansion in Africa Following Approval
Aspen's Mounjaro expansion plans promise to enhance diabetes and weight management treatment in Sub-Saharan Africa soon.